Lodaer Img

Precision Therapy

Precision therapy, also known as precision medicine, is a cutting-edge approach to cancer treatment that considers the individual variability in genes, environment, and lifestyle for each person. Unlike traditional treatments that take a one-size-fits-all approach, precision therapy targets the specific genetic mutations and molecular characteristics of a patient’s tumor. This helps doctors select the most effective therapy while minimizing unnecessary side effects.
Precision therapy uses advanced diagnostic tools such as genomic testing, molecular profiling, and biomarker analysis to guide treatment decisions. It is transforming the way many cancers are treated, offering patients more personalized and often more effective care.

What does precision therapy involve?

Precision therapy involves the use of targeted drugs or immunotherapy tailored to a tumor’s specific genetic profile. These therapies block the growth and spread of cancer by interfering with specific molecules involved in tumor progression. This approach is most commonly used in cancers such as breast, lung, colorectal, and certain blood cancers, where specific gene mutations have been identified.
  • Genomic testing to detect mutations or alterations in cancer-related genes
  • Targeted therapy to block abnormal proteins or pathways driving tumor growth
  • Immunotherapy to boost the body’s natural defenses to fight cancer
  • Use of biomarkers to predict response to specific treatments
  • Monitoring treatment effectiveness through molecular imaging and blood tests

What Precision Therapy targets

Precision oncologists acquire deep knowledge in genomics, molecular biology, and pharmacogenomics to interpret complex test results and tailor treatments to the individual. They are skilled in selecting appropriate targeted therapies, managing side effects, and adapting treatment plans as new information emerges. Precision therapy is at the forefront of personalized cancer care, offering hope for better outcomes, fewer side effects, and improved quality of life. It represents a major shift in oncology—from treating the cancer type to treating the cancer’s unique genetic fingerprint.